Organon & Co (OGN) — Capital Reinvestment Ratio
Organon & Co (OGN) has a Capital Reinvestment Ratio of 0.16x as of March 2026, meaning it reinvests 0% of its operating cash flow ($225.00 Million) in capital expenditures ($37.00 Million). See Organon & Co net asset quality index to measure how much of total assets are equity-financed.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
Organon & Co Capital Reinvestment Ratio (2017–2025)
This chart tracks Organon & Co's Capital Reinvestment Ratio across 9 annual periods. Check total reinvestment intensity of Organon & Co to assess the company's total reinvestment commitment from operating cash flow.
Annual Capital Reinvestment Ratio for Organon & Co (2017–2025)
Year-by-year Capital Reinvestment Ratio for Organon & Co from 2017 to 2025. For live market cap and broader valuation context, see Organon & Co (OGN) market capitalisation.
| Year | Reinvestment Ratio | Operating CF (USD) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2025 | 0.23x | $700.00 Million | $162.00 Million | ▼ -38.1% |
| 2024 | 0.37x | $939.00 Million | $351.00 Million | ▲ +14.4% |
| 2023 | 0.33x | $799.00 Million | $261.00 Million | ▼ -34.4% |
| 2022 | 0.50x | $858.00 Million | $427.00 Million | ▲ +150.7% |
| 2021 | 0.20x | $2.46 Billion | $488.00 Million | ▲ +56.2% |
| 2020 | 0.13x | $2.19 Billion | $278.00 Million | ▲ +282.3% |
| 2019 | 0.03x | $2.77 Billion | $92.00 Million | ▲ +21.4% |
| 2018 | 0.03x | $3.69 Billion | $101.00 Million | ▲ +8.9% |
| 2017 | 0.03x | $3.42 Billion | $86.00 Million | — |